Agoraphobia
Fear of places and situations that might cause panic, helplessness, or embarrassment.
Agoraphobia is an anxiety disorder that often develops after one or more panic attacks.
Symptoms include fear and avoidance of places and situations that might cause feelings of panic, entrapment, helplessness, or embarrassment.
Treatments include talk therapy and medication.
Cluster Number: F-1
Wiki Number: W003
Diagnosis: Agoraphobia
US Patients: 1.7% Adults
World Patients:
Sex Ratio: M-2W
Age Onset: 20+
Brain Area: Extra epinephrine – poor balance
Symptoms: environment unsafe-no escape
Progression: Open spaces or outside home; may lead to 10-30 minute panic attack or PTSD
Causes:
Medications: antidepressants; anti-anxiety
Therapies: relaxation, systematic desensitization, expanding exposuresCBT-50%
Youtube Video: What is Agoraphobia?
Amazon or Library Book:
The Agoraphobia Workbook
Click on the book to link or buy from Amazon.
Contact your local Social Security office for possible Disability Benefits through their Disability Determination Services,
Section 12.06.
4 CURRENT ARTICLES
FROM PUBMED
The world-wide medical research
reports chosen for each diagnosis
Clicking each title opens the
PubMed article’s summary-abstract.
- Structural Study of Anxiety and Mood-related Symptomatology in Psychiatric Outpatientsby Johann M Vega-Dienstmaier on December 19, 2024
CONCLUSION: Overlapping and/or highly correlated psychiatric syndromes were prominent findings, underlining the pertinence of a dimensional approach as a substantial strategy toward a more inclusive understanding of mental disorders.
- App-Based Psychotherapy of Panic Disorder with Self-Guided Exposure in Virtual Reality—a Randomized, Controlled Trialby Josephine Schultz on December 4, 2024
CONCLUSION: A digital treatment with virtual exposure can lessen anxiety, panic, and depressive symptoms and improve mental flexibility. In further studies, IVT should be compared with an active control group.
- The potential effect of d-cycloserine on the development of anxiety during exposure sessions in patients with agoraphobiaby L Pyrkosch on November 30, 2024
INTRODUCTION: Combination of exposure therapy with d-cycloserine (DCS) in patients suffering from anxiety disorders yielded promising results regarding treatment outcomes. However, less is known about short-term effects of DCS during the treatment process, e. g. its potential influence on anxiety during exposure sessions. In this exploratory secondary analysis using data from a randomized, double-blind, placebo-controlled trial, we investigated longitudinal changes in anxiety during exposure in...
- Cost-effectiveness analysis of mindfulness-based cognitive therapy in patients with anxiety disorders in secondary mental health care settings alongside a randomized controlled trialby Mitsuhiro Sado on November 11, 2024
INTRODUCTION: Anxiety disorder is one of the most prevalent mental disorders. Mindfulness-based cognitive therapy (MBCT) is effective for treating anxiety disorders. However, no studies have investigated the cost-effectiveness of MBCT for anxiety disorders. We aimed to conduct a cost-effectiveness analysis alongside a randomized controlled trial (RCT) to clarify the cost-effectiveness of MBCT for anxiety disorders.